SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-11-007358
Filing Date
2011-08-12
Accepted
2011-08-12 17:29:18
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 19-Q a2205190z10-q.htm 10-Q 411589
2 EX-31.1 a2205190zex-31_1.htm EX-31.1 7704
3 EX-31.2 a2205190zex-31_2.htm EX-31.2 7750
4 EX-32.1 a2205190zex-32_1.htm EX-32.1 4679
  Complete submission text file 0001047469-11-007358.txt   1818498

Data Files

Seq Description Document Type Size
5 EX-101.INS hlcs-20110630.xml EX-101.INS 156709
6 EX-101.SCH hlcs-20110630.xsd EX-101.SCH 11025
7 EX-101.CAL hlcs-20110630_cal.xml EX-101.CAL 43629
8 EX-101.LAB hlcs-20110630_lab.xml EX-101.LAB 194303
9 EX-101.PRE hlcs-20110630_pre.xml EX-101.PRE 96891
10 EX-101.DEF hlcs-20110630_def.xml EX-101.DEF 66414
Mailing Address ONE KENDALL SQUARE BUILDING 200 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200 CAMBRIDGE MA 02139 617-649-0540
HELICOS BIOSCIENCES CORP (Filer) CIK: 0001274563 (see all company filings)

IRS No.: 050587367 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33484 | Film No.: 111032432
SIC: 2834 Pharmaceutical Preparations